On March 22, 2018, the Centers for Medicare & Medicaid Services (CMS) put on display CMS-2397-FN, the final notice that announced changes to the Medicaid National Drug Rebate Agreement (NDRA), which will be applicable as of the March 23, 2018 publication in theFederal Register. The updated NDRA can be viewed at the following link:https://www.federalregister.
gov/documents/2018/03/23/2018- 05947/medicaid-program- announcement-of-medicaid-drug- rebate-program-national- rebate-agreement
The updated NDRA incorporates legislative and regulatory changes that have occurred since the NDRA was last published on February 21, 1991, and also makes editorial and structural revisions, such as references to the updated Office of Management and Budget (OMB)-approved data collection forms and electronic data reporting. Manufacturers with an existing active NDRA(s) as of the applicability date of the notice have until September 30, 2018 to complete (including the CMS-367d), sign and submit the updated NDRA in order to continue participation in the Medicaid Drug Rebate Program (MDRP). Please stay tuned for more information on the updated NDRA.
If you have any questions regarding the updated NDRA, please contact DrugRebateAgreement@cms.hhs.